Published on 1 Mar 2024 on Simply Wall St. via Yahoo Finance
An Intrinsic Calculation For Fulgent Genetics, Inc. (NASDAQ:FLGT) Suggests It's 32% Undervalued
Key Insights
The projected fair value for Fulgent Genetics is US$33.29 based on 2 Stage Free Cash Flow to EquityFulgent Genetics' US$22.56 share price signals that it might be 32% undervalued Analyst price target for FLGT is US$29.33 which is 12% below our fair value estimate
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Fulgent Genetics, Inc. (NASDAQ:FLGT) as an investment opportunity by estimating the company's future cash flows and discounting them to their present value. We will take advantage of the Discounted Cash Flow (DCF) model for this purpose. It may sound complicated, but actually it is quite simple!